Analysts forecast that Albemarle Co. (NYSE:ALB) will announce earnings of $1.19 per share for the current quarter, Zacks reports. Four analysts have issued estimates for Albemarle’s earnings, with the lowest EPS estimate coming in at $1.15 and the highest estimate coming in at $1.31. Albemarle reported earnings per share of $1.05 during the same quarter last year, which would suggest a positive year over year growth rate of 13.3%. The business is scheduled to report its next quarterly earnings results on Wednesday, May 2nd.
According to Zacks, analysts expect that Albemarle will report full year earnings of $5.11 per share for the current fiscal year, with EPS estimates ranging from $5.00 to $5.30. For the next fiscal year, analysts forecast that the business will post earnings of $5.75 per share, with EPS estimates ranging from $5.25 to $6.00. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side analysts that that provide coverage for Albemarle.
Albemarle (NYSE:ALB) last issued its earnings results on Tuesday, February 27th. The specialty chemicals company reported $1.34 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.13. The firm had revenue of $857.79 million during the quarter, compared to the consensus estimate of $791.46 million. Albemarle had a net margin of 1.79% and a return on equity of 13.27%.
Several large investors have recently made changes to their positions in the company. Golden Gate Private Equity Inc. raised its holdings in shares of Albemarle by 1.5% in the third quarter. Golden Gate Private Equity Inc. now owns 25,870 shares of the specialty chemicals company’s stock valued at $3,526,000 after buying an additional 370 shares during the last quarter. First Citizens Bank & Trust Co. raised its holdings in shares of Albemarle by 6.8% in the fourth quarter. First Citizens Bank & Trust Co. now owns 6,431 shares of the specialty chemicals company’s stock valued at $822,000 after buying an additional 411 shares during the last quarter. Colony Group LLC raised its holdings in shares of Albemarle by 3.9% in the third quarter. Colony Group LLC now owns 12,880 shares of the specialty chemicals company’s stock valued at $1,756,000 after buying an additional 479 shares during the last quarter. Banque Pictet & Cie SA raised its holdings in shares of Albemarle by 0.9% in the third quarter. Banque Pictet & Cie SA now owns 53,142 shares of the specialty chemicals company’s stock valued at $7,244,000 after buying an additional 499 shares during the last quarter. Finally, Eagle Boston Investment Management Inc. raised its holdings in shares of Albemarle by 4.0% in the third quarter. Eagle Boston Investment Management Inc. now owns 13,422 shares of the specialty chemicals company’s stock valued at $1,833,000 after buying an additional 521 shares during the last quarter. 86.42% of the stock is owned by institutional investors and hedge funds.
Shares of Albemarle (ALB) traded up $1.23 during mid-day trading on Monday, hitting $102.99. 1,508,855 shares of the company were exchanged, compared to its average volume of 2,800,000. The company has a current ratio of 2.06, a quick ratio of 1.57 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $11,380.00, a P/E ratio of 24.23, a P/E/G ratio of 1.22 and a beta of 1.59. Albemarle has a 12-month low of $90.49 and a 12-month high of $144.99.
The firm also recently announced a quarterly dividend, which will be paid on Monday, April 2nd. Stockholders of record on Thursday, March 15th will be issued a $0.335 dividend. This represents a $1.34 dividend on an annualized basis and a dividend yield of 1.30%. This is a boost from Albemarle’s previous quarterly dividend of $0.32. The ex-dividend date of this dividend is Wednesday, March 14th. Albemarle’s dividend payout ratio is presently 30.12%.
TRADEMARK VIOLATION NOTICE: “Analysts Anticipate Albemarle Co. (ALB) Will Post Earnings of $1.19 Per Share” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://www.americanbankingnews.com/2018/03/12/analysts-anticipate-albemarle-co-alb-will-post-earnings-of-1-19-per-share.html.
Albemarle Company Profile
Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.